Cargando…
Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy
For the optimal management of refractory ulcerative colitis (UC), secondary loss of response (LOR) and primary non-response to biologics is a critical issue. This article aimed to summarize the current literature on the use of cytapheresis (CAP) in patients with UC showing a poor response or LOR to...
Autores principales: | Iizuka, Masahiro, Etou, Takeshi, Sagara, Shiho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494931/ https://www.ncbi.nlm.nih.gov/pubmed/36160647 http://dx.doi.org/10.3748/wjg.v28.i34.4959 |
Ejemplares similares
-
Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis
por: Iizuka, Masahiro, et al.
Publicado: (2021) -
Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis
por: Iizuka, Masahiro, et al.
Publicado: (2017) -
Novel oral-targeted therapies for mucosal healing in ulcerative colitis
por: Antonelli, Elisabetta, et al.
Publicado: (2018) -
Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023) -
Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?
por: Andrew, Rachel E, et al.
Publicado: (2016)